Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers
- Status
- TERMINATED
- Phase
- N/A
Clinical Trials Related to Metastatic Prostate Cancer
Related studies linked through entity extraction aliases.
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs)
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Natural Killer Cells in Patients With Metastatic Prostate Cancer: Relationship With Survival and Response Time to Castration
- Status
- UNKNOWN
- Phase
- NA
One-year, Open Extension to Evaluate the Treatment of Patients With Castration-Resistant Prostate Cancer With YONSA™
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Activity Study of PSCA-Targeted CAR-T Cells (BPX-601) in Subjects With Selected Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Enzalutamide and Niraparib in the Treatment of Metastatic Castrate-Resistant Prostate Cancer (CRPC)
- Status
- TERMINATED
- Phase
- PHASE1
Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)
- Status
- COMPLETED
- Phase
- N/A
Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Prospective Evaluation of Stereotactic Body Radiotherapy for Metastatic Prostate Cancer
- Status
- WITHDRAWN
- Phase
- NA
Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- N/A
Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Abiraterone Acetate in Combination With Docetaxel After Disease Progression to Abiraterone Acetate in Metastatic Castration Resistant Prostate Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Sipuleucel-T With Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3